ArticleScientific reports2023

Dual species sphingosine-1-phosphate lyase inhibitors to combine antifungal and anti-inflammatory activities in cystic fibrosis: a feasibility study.

Barbara Cellini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.